A Feasibility Study to Evaluate Skin Cleansing With a Sodium Hypochlorite Wash
Launched by TOPMD SKIN CARE, INC. · May 21, 2018
Trial Information
Current as of May 29, 2025
Withdrawn
Keywords
ClinConnect Summary
This is a feasibility study in approximately 20 subjects over a 5-week period per subject. The study will investigate the rate of infection with subjects undergoing elective lower extremity arterial bypass graft surgery or femoral endarterectomy. The subjects are instructed to shower with the sodium hypochlorite body wash daily, or as modified by the physician, for 5 of the 7 days leading to their surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subject is male or female greater than the age of 18 years.
- • 2. Subject is willing and able to give written informed consent and to comply with the requirements of the study.
- • 3. Subject has 5 or more days of time prior to elective surgery scheduled to sign consent and begin washing parameters.
- • 4. Subject is capable of taking a shower and lathering their entire body, or is able to be helped by a caregiver to shower each day with lather on their entire body for 5 out of 7 days immediately prior to elective surgery. (Modifications for bath usage can be made by the physician if the result of the product being left on the skin of the entire body for the time commitment is maintained, and if the body can be rinsed with poured water. Bed bath is not considered an allowable modification.)
- Exclusion Criteria:
- • 1) Subject is on antibiotics prior to surgery.
- • 2) Subject is unable to maintain washing regimen for the full study term.
- • 3) Subject is unable to follow pre-surgery cleansing instructions for 5 of the 7 days immediately prior to surgery. (Bed bath is not considered a cleansing day.)
About Topmd Skin Care, Inc.
TopMD Skin Care, Inc. is a leading clinical trial sponsor dedicated to advancing dermatological research and innovation. With a focus on developing effective and safe skin care products, the company employs rigorous scientific methodologies and collaborative partnerships to conduct clinical trials that assess the efficacy and safety of its formulations. Committed to improving patient outcomes and enhancing skin health, TopMD Skin Care, Inc. leverages cutting-edge technology and expert insights to bring transformative solutions to the market, ensuring that its products meet the highest standards of quality and effectiveness.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Trial Officials
Stephen E Hohmann, MD
Principal Investigator
Texas Vascular Associates
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials